Sector
PharmaceuticalsOpen
₹48.75Prev. Close
₹50.44Turnover(Lac.)
₹3.26Day's High
₹50.5Day's Low
₹48.7552 Week's High
₹94.952 Week's Low
₹45.15Book Value
₹8.73Face Value
₹10Mkt Cap (₹ Cr.)
36.73P/E
0EPS
0Divi. Yield
09 Aug 2024
12:00 AM
AGM
Announcement Date: 09 Aug, 2024
9 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 7.42 | 7.42 | 7.42 | 7.42 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -0.31 | -0.56 | 1.11 | 0.24 |
Net Worth | 7.11 | 6.86 | 8.53 | 7.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 40.13 | 25.17 | 37.54 | 29.01 |
yoy growth (%) | 59.4 | -32.93 | 29.39 | 14.73 |
Raw materials | -15.24 | -9.99 | -13.9 | -10.52 |
As % of sales | 37.99 | 39.68 | 37.03 | 36.25 |
Employee costs | -15.82 | -12.96 | -15.12 | -11.92 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.74 | -2.53 | 0.43 | 0.32 |
Depreciation | -0.27 | -0.17 | -0.24 | -0.18 |
Tax paid | 0.12 | 0.01 | -0.15 | -0.05 |
Working capital | 2 | -0.44 | 2.46 | -5.43 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 59.4 | -32.93 | 29.39 | 14.73 |
Op profit growth | -140.37 | -505.13 | 111.34 | 304.73 |
EBIT growth | -153.58 | -394.3 | 31.98 | 65.61 |
Net profit growth | -134.61 | -1,012.54 | 1.98 | -1,928.47 |
| Particulars (Rupees in Crores.) | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|
Gross Sales | 25.18 | 37.54 | 31.03 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 25.18 | 37.54 | 31.03 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 0.8 | 0.29 | 0.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.25 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,785.4 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.45 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.35 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,640.6 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Amrutbhai P Prajapati
Independent Director
Chhayaben Ashwinbhai Shah
Independent Director
Viplav Suryakantbhai Khamar
Managing Director & Chief Executive Officer
Aalap Prajapati
Independent Director
Surendra Kumar Sharma
Independent Director
Navinchandra Patel
Chairman & Wholetime Director
Natwarbhai P Prajapati
122/2 Ravi Estate,
Bileshwarpura Chhatral,
Gujarat - 382729
Tel: 91-079-6663 3706
Website: http://www.gtll.in; www.gujaratterce.com
Email: [email protected]
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: [email protected]
Summary
Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market. Over its more than three-decade business journey, the Company developed an exte...
Read More
Reports by Gujarat Terce Laboratories Ltd
What is the Gujarat Terce Laboratories Ltd share price today?
What is the Market Cap of Gujarat Terce Laboratories Ltd?
What is the PE and PB ratio of Gujarat Terce Laboratories Ltd?
What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?
What is the CAGR of Gujarat Terce Laboratories Ltd?
What is the shareholding pattern of Gujarat Terce Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.